跳到主要內容
big screen image small screen image
Font Size
A
A
A
轉寄 轉寄
(Non-exclusive License)Technology Transfer Enterprise Selection Announcement – Anti-phospo-EBP50(Ser347 and 348) polyclonal antibodies
Date of Announcement
2023-07-26

1、Technology:Anti-phospo-EBP50(Ser347 and 348) polyclonal antibodies


2、Inventor:Prof. Tzuu - Shuh Jou / Gradute Institute of clinical Medicine, National Taiwan University

 

3、Enterprise Eligibility:
(1)Industry Category:Biomedical Science
(2)Required Technical Know-how:peptide synthesis and antibody purification
(3)Required Machinery and Equipment:antibody production and biochemical analysis and testing equipment
(4)Required Research or Technical Staff:personnel with molecular biology and antibody purification
(5)Other Requirements:None


4、How to apply:Please go to the Center of Industrial-Academic Cooperation of the Office of Research and Development to inquire about relevant information.


5、Announcement period:will be accepted from the announcement date.

 

6、Contact window:
Intellectual Property & Licensing Manager:LutePan
TEL:+886-2-3366-9951
Email:lutepan@ntu.edu.tw

 

7.  Please refer to the attachment for the technical disclosure information of this case, and download the documents required for the application from the link

File download:
TechnologyTransferEnterpriseSelection-Anti-phospo-EBP50(Ser347and348)polyclonalantibodies
File size: 325kb